ArticleJournal of patient-reported outcomes2023

Use of patient-reported outcomes (PRO) data to complement exposure-response analysis in early clinical cancer drug development.

Huiming Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.